Trademark: 90765835
Word
LYBALVI
Status
Pending
Status Code
748
Status Date
Friday, May 26, 2023
Serial Number
90765835
Mark Type
4000
Filing Date
Thursday, June 10, 2021
Published for Opposition
Tuesday, May 31, 2022

Trademark Owner History
Alkermes Pharma Ireland Limited - Owner At Publication

Classifications
36 Providing information about pharmaceutical coverage by patient health plans; providing insurance administration information to patients and health care providers about medication reimbursement options; insurance services being support services for patients and for health care providers on behalf of their patients, namely, providing health benefit verification services to determine coverage of medication treatment; financial administration of medication reimbursement programs being support services for patients and for health care providers on behalf of their patients, namely, coordinating medication reimbursement programs
35 Logistics management in the field of medication, namely, business services in the nature of supporting the coordination of medication delivery to avoid product delivery delays; providing business administration information to patients and health care providers about medication reimbursement options regarding reimbursement procedures; providing information about pharmaceutical services, namely, providing information about pharmacy authorization in the nature of prescription fulfillment and approval instructions for delivery of medication in the nature of accepting payment terms
45 Support services for health care providers and their patients in the nature of providing case management services, namely, coordinating the procurement of medication in the nature of conducting benefits verification with payers to facilitate prescription fulfilment and coordinating with non-commercial pharmacy to facilitate prescription fulfilment for patients eligible for patient assistance program; providing case management services in the nature of support services for patients and for health care providers on behalf of their patients, namely, coordinating the procurement of medication in the nature of conducting benefits verification with payers to facilitate prescription fulfilment and coordinating with non-commercial pharmacy to facilitate prescription fulfilment for patients eligible for patient assistance program
44 Providing educational information in the field of medication treatment to health care providers and patients; providing educational information about the diagnostic, prophylactic, and therapeutic properties of pharmaceuticals and pharmaceutical products for medical purposes

Trademark Events
May 27, 2023
Notice Of Approval Of Extension Request E-Mailed
May 26, 2023
Statement Of Use Processing Complete
May 26, 2023
Sou Extension 1 Granted
May 19, 2023
Sou Extension 1 Filed
May 19, 2023
Use Amendment Filed
May 25, 2023
Case Assigned To Intent To Use Paralegal
May 19, 2023
Teas Extension Received
May 19, 2023
Teas Statement Of Use Received
Nov 29, 2022
Noa E-Mailed - Sou Required From Applicant
Oct 17, 2022
New Noa To Issue
Jul 26, 2022
Notice Of Allowance Cancelled
Jul 28, 2022
Noa E-Mailed - Sou Required From Applicant
May 31, 2022
Official Gazette Publication Confirmation E-Mailed
May 31, 2022
Published For Opposition
May 11, 2022
Notification Of Notice Of Publication E-Mailed
Apr 26, 2022
Approved For Pub - Principal Register
Apr 26, 2022
Examiner's Amendment Entered
Apr 26, 2022
Notification Of Examiners Amendment E-Mailed
Apr 26, 2022
Examiners Amendment E-Mailed
Apr 26, 2022
Examiners Amendment -Written
Apr 15, 2022
Previous Allowance Count Withdrawn
Mar 29, 2022
Withdrawn From Pub - Og Review Query
Mar 14, 2022
Approved For Pub - Principal Register
Mar 14, 2022
Examiner's Amendment Entered
Mar 14, 2022
Notification Of Examiners Amendment E-Mailed
Mar 14, 2022
Examiners Amendment E-Mailed
Mar 14, 2022
Examiners Amendment -Written
Mar 11, 2022
Previous Allowance Count Withdrawn
Mar 11, 2022
Withdrawn From Pub - Managing Attorney Request
Mar 7, 2022
Approved For Pub - Principal Register
Mar 1, 2022
Assigned To Examiner
Aug 30, 2021
New Application Office Supplied Data Entered
Jun 14, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24